A phenome-wide association study of tandem repeat variation in 168,554 individuals from the UK Biobank

Celine A. Manigbas; Bharati Jadhav; Paras Garg; Mariya Shadrina; William Lee; Alejandro Martin-Trujillo; Andrew J. Sharp

doi:10.1101/2024.01.22.24301630

Abstract

Most genetic association studies focus on binary variants. To identify the effects of multi-allelic variation of tandem repeats (TRs) on human traits, we performed direct TR genotyping and phenome-wide association studies in 168,554 individuals from the UK Biobank, identifying 47 TRs showing causal associations with 73 traits. We replicated 23 of 31 (74%) of these causal associations in the All of Us cohort. While this set included several known repeat expansion disorders, novel associations we found were attributable to common polymorphic variation in TR length rather than rare expansions and include e.g. a coding polyhistidine motif in HRCT1 influencing risk of hypertension and a poly(CGC) in the 5’UTR of GNB2 influencing heart rate. Causal TRs were strongly enriched for associations with local gene expression and DNA methylation. Our study highlights the contribution of multi-allelic TRs to the “missing heritability” of the human genome.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This research has been conducted using the UK Biobank Resource under Application Number 82094 and the NIH All of Us data under research project "Association studies of tandem repeats". This work was supported by NIH grants AG075051, NS105781 and HD103782 to A.J.S. and NHLBI BioData Catalyst Fellowship #5120339 to A.M.T.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

Collection of the UKB data was approved by the Research Ethics Committee of the UKB obtained under application 32568. All study participants provided informed consent, and the protocols for UKB are overseen by The UKB Ethics Advisory Committee, see https://www.ukbiobank.ac.uk/ethics/.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes